Publikationen, an denen er mitarbeitet O. Pfaar (10)

2021

  1. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 3, pp. 1020-1030.e10

  2. Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 4, pp. 1041-1052

  3. Placebo effects in allergen immunotherapy—An EAACI Task Force Position Paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 3, pp. 629-647

2019

  1. Comparison of International Systemic Adverse Reactions Due to Allergen Immunotherapy

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 4, pp. 1298-1305.e3

2018

  1. Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 4, pp. 827-836

2017

  1. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 72, Núm. 3, pp. 462-472

  2. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment

    Pediatric Allergy and Immunology, Vol. 28, Núm. 1, pp. 60-70